)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Zhangzhou Pientzehuang Pharmaceutical
Zhangzhou Pientzehuang Pharmaceutical (600436) investor relations material
Zhangzhou Pientzehuang Pharmaceutical Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary18 Oct, 2025
Executive summary
Revenue for Q3 2025 was RMB 2.06 billion, down 26.28% year-over-year; YTD revenue was RMB 7.44 billion, down 11.93% year-over-year.
Net profit attributable to shareholders for Q3 was RMB 687 million, down 28.82% year-over-year; YTD net profit was RMB 2.13 billion, down 20.74% year-over-year.
Declines attributed to reduced sales and lower gross margins in the pharmaceutical manufacturing segment.
Financial highlights
Q3 total profit was RMB 779 million, down 30.78% year-over-year; YTD total profit was RMB 2.49 billion, down 22.05%.
Basic and diluted EPS for Q3 were RMB 1.14, down 28.75% year-over-year; YTD EPS was RMB 3.53, down 20.67%.
Net cash flow from operating activities for Q3 was RMB 486.7 million, down 62.53% year-over-year.
Non-recurring gains for the period included government subsidies and fair value changes in financial assets, totaling RMB 249 million for Q3.
Outlook and guidance
Management attributes profit and cash flow declines to lower sales and margin compression, with no explicit forward guidance provided.
医药制造业销售和毛利率下降原因?
经营现金流大幅下降影响及应对?
投资活动现金流变化及金融资产策略?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Zhangzhou Pientzehuang Pharmaceutical
- Revenue up 7.06% and net profit up 6.32% year-over-year, with margin pressure from raw material costs.600436
H2 202415 Dec 2025 - H1 2024 revenue up 12% and net profit up 11.7%, with margin pressure from higher costs.600436H1 202415 Dec 2025
- Net profit fell 16.22% year-over-year, with strategic R&D and expansion investments ongoing.600436H1 202515 Dec 2025
- Double-digit revenue and profit growth offset by a significant drop in operating cash flow.600436Q3 202413 Jun 2025
- Net profit up 2.59% year-over-year in Q1 2025, with strong cash flow growth.600436Q1 20256 Jun 2025
Next Zhangzhou Pientzehuang Pharmaceutical earnings date
H2 202530 Apr, 2026
Zhangzhou Pientzehuang Pharmaceutical
Next Zhangzhou Pientzehuang Pharmaceutical earnings date
H2 202530 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage